March 24, 2014 Comments Off on Biotech Stocks Slide – Market Correction, or IPO Window Slamming Shut? Posted in: General Biotechnology 2013 and 2014 have been very good for biotechnology public markets. 35 biotechnology companies went public in 2013, and well over a dozen have gone public in the first few months of 2014. With the surge in public launches, one must ask the question: “How long can it last?” Just a few days ago Barrons’s […]
March 19, 2014 Comments Off on Viagra Compulsory Licensing – What Becomes an (Urban) Legend Most Posted in: General Biotechnology This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below. Have you heard the urban legend about Egypt’s compulsory license for Viagra, following declaration of a national emergency for erectile dysfunction? Its a whale of a tale, combining crony […]
